Medical Aesthetic News

 In the field of aesthetic medicine, high device usage is more than a number — it reflects accumulated clinical expertise and patient trust. The Top Rankers series spotlights physicians who have achieved consistently high real-world usage in their own practices. This installment features Dr. Gwahn Woo Cheon of Maylin Clinic Pangyo, named Top Ranker for SHENB's combined monopolar-bipolar RF platform, Sunny. Having worked extensively with major monopolar RF devices, he chose Sunny as his primary platform for its ADRT technology — expanding indications from lifting to melasma and pigmentation — and the Quasar tip's ability to conform to curved anatomy and the scalp. Describing Sunny as "a device that delivers both efficacy and cost-effectiveness," Dr. Cheon shares his full-face 1,200-shot 'Double Sunny' protocol, his Soft mode level 2.5 'golden parameter,' and insights from a melasma clinical study with Professor Kyunghee Byun's team.  #MedicalAesthet...

 KIMES 2026 Special, Part 2. Following Part 1 on the evolution of energy-based devices, we covered the new growth engines emerging beyond EBD. Clinical interest is no longer confined to energy-based devices alone. How drugs reach the dermis, how energy and drugs are combined in a single procedure, and how the range of available formulations is expanding — delivery, combination, and formulation are increasingly shaping the competitiveness of the overall treatment strategy. Needle-free injectors and needle-based delivery platforms are changing how drugs reach the dermis. A hybrid injector combining drug injection and RF in one device has emerged. And companies are expanding their formulation portfolios beyond exosomes to include biostimulators and HA fillers for the combination-treatment era. We visited four companies — BAZ BIOMEDIC, Curiosis, Huons Meditech, and Primoris International — on the exhibition floor to document this shift firsthand.  #MedicalAestheticNews #KIMES2026 ...

 The skin booster market is evolving beyond simple drug delivery toward multi-modality treatments. As patients and clinicians increasingly look beyond a single-modality approach, there is growing interest in integrated injectors that combine drug infusion and radiofrequency stimulation in one platform. The Dermashine Duo_RF is a next-generation hybrid injector designed to meet this demand, accelerating the collagen response and improving delivery efficiency. We sat down with Dr. Jonghoon Lee of Lyzbelle Clinic, who has used the Dermashine series — the established reference in injector technology — since 2015, to discuss synergies with polymers, PRP, and exosomes, reduction in treatment sessions, real-world RF parameter settings, and combination treatment strategies. #MedicalAestheticNews #HuonsMeditech #Dermashine #Dermashine_Duo_RFShineDuoRF #LyzbelleClinic #DrJonghoonLee ★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=11006

 With HIFU and RF firmly established as the two pillars of the lifting and tightening market, a picosecond laser-based approach known as PicoSculpting is emerging as a third option. LASEROPTEK's SCULPIO is a next-generation platform equipped with dedicated PS handpieces for PicoSculpting, adding facial contouring and skin tightening to the conventional pigment and toning repertoire. At the LEAD Symposium in January, Dr. Jaehong Kim of Yonsei Joeun Dermatology Clinic (Gwangmyeong) presented "The Start of 2026: My Choice Is SCULPIO." We sat down with Dr. Kim to discuss what led him to adopt SCULPIO, his combination treatment strategy, how he addresses the fine details that HIFU and RF leave behind, and how he keeps 'skincare nomads' coming back.  #MedicalAestheticNews #LASEROPTEK #SCULPIO #PicoSculpting #DrJaehongKim #YonseiJoeunDermatology ★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=11286

 We visited KIMES 2026 in person. The 41st Korea International Medical & Hospital Equipment Show, held from March 19 to 22 at COEX in Seoul, drew approximately 1,490 exhibitors from 41 countries and more than 70,000 visitors. This year, the aesthetics pavilion 'BEAUTY & DERMA Seoul' expanded its floor space from the previous year, expanding the global reach of K-medical aesthetics. While AI and digital health dominated the exhibition floor, the medical aesthetics sector was telling a different story. Korean EBD companies — long established in overseas markets — are reshaping the competitive landscape not through higher power specs, but through indication expansion and global regulatory clearance. We visited the booths of six companies — LASEROPTEK, SHENB, VIOL Medical, LTRA Global, Chungwoo Medical, and Speclipse — to document this shift firsthand.  #MedicalAestheticNews #KIMES2026 #KMedicalAesthetics #LASEROPTEK #SHENB #VIOLMedical #LTRAGlobal #ChungwooMedical #Specli...

 In aesthetic medicine, a high procedural volume for a specific product is more than a number — it reflects accumulated clinical expertise and patient trust built through consistent outcomes. The Top Rankers series spotlights the practitioners who have built those real-world track records. This edition features Dr. Changhwan Cho of Dongan Joongsim Clinic, who recorded the highest case volume for HILO WAVE in the shortest period since its launch. HILO WAVE is an HA-based biostimulator by HIGHER Corporation. A longtime researcher in anti-aging medicine, Dr. Cho made HILO WAVE his primary biostimulator for two decisive reasons: immediate reversibility via hyaluronidase, and the biological activity within the ECM enabled by its proprietary DHC (Dual Hyaluronic Acid Compound) structure. "Being able to perform the procedure without stress — that is the advantage," he emphasizes. From his criteria for choosing between the P.D.I.T. and waving cannulation protocols, to energy-based de...

 Primoris International continued its active global expansion at IMCAS World Congress 2026 in Paris, led by its P198 exosome skin booster line. We spoke with Dr. Hosung Choi (LIEUL Clinic, Seoul), who served as a speaker at the company's open lecture at the booth to share his clinical experience. P198 comprises two products: ExoHealer, based on umbilical cord blood stem cell-derived exosomes, and ExoNature, based on Panax ginseng-derived plant exosomes. Dr. Choi noted that "the more I learned, the more I realized how much exosome quality matters," explaining why he chose UCB-derived P198. His presentation drew particular attention for introducing lip rejuvenation as a novel indication, and he emphasized that "the anti-inflammatory effect is what makes exosomes truly stand out among skin boosters." He also observed that "the influence of K-Beauty is not fading — it is only getting stronger," crediting Korea's manufacturing excellence for the expansi...

 As Solta Medical continued expanding its global presence at IMCAS World Congress 2026 in Paris — showcasing its key portfolio, led by Thermage FLX — we sat down with Dr. Haeun Lee, Director of Foret Dermatology and a Solta Medical KOL, to hear about her clinical experience. Dr. Lee likened Thermage FLX to "a savings plan for your skin," noting that "the key is to stay consistent with about one session a year." Having initially started with a Korean monopolar RF device before switching to Thermage, she pointed to longevity of results as "the decisive difference" — explaining why patients return despite nearly double the cost. She also presented a case in which a patient in her mid-70s achieved a visible lifting effect with 900 shots, highlighting the potential even in older patients. On Eye Thermage, she called it "a treatment that cannot truly be replaced." As Public Relations Director of the Association of Korean Dermatologists, she added that ...

 Primoris International continued its active global expansion at IMCAS World Congress 2026 in Paris, led by its P198 exosome skin booster line. We spoke with Dr. Kyungtae Bae (Itsme Clinic, Sejong), who served as a speaker at the company's open lecture at the booth to share his clinical experience. P198 comprises two products: ExoHealer, based on umbilical cord blood stem cell-derived exosomes, and ExoNature, based on Panax ginseng-derived plant exosomes. Dr. Bae noted that he had been "looking for safe exosomes from a reliable source," and shared his clinical experience in treating inflammatory skin conditions, melasma, and acne — noting a rapid clinical response and meaningful improvement in skin barrier recovery. He also observed that "international trust in Korean exosome products is growing, and we are in a process of advancing together with physicians abroad," underscoring the rising stature of K-Medical Aesthetics on the global stage.  #MedicalAestheticNe...

 Chungwoo Medical, an RF technology-focused medical device manufacturer, showcased its cannula-based monopolar RF device 'APOLEX Tite' at IMCAS World Congress 2026 in Paris. On-site, we spoke with Dr. Hyunseok Nam (OWN Clinic, Songdo), who serves as a KOL for the device, about his clinical experience. Dr. Nam first turned to APOLEX Tite to help manage complications such as nodules following collagen stimulator procedures, citing its specially coated cannula and real-time temperature and impedance control system as the device's key differentiators. "It's a device I'd rather keep to myself," he noted, adding that "efficacy is a given, but APOLEX Tite's real strength lies in the added layer of safety." He also emphasized the growing global standing of K-Medical Aesthetics, stating his commitment to championing technically capable Korean companies as they expand onto the world stage.  #MedicalAestheticNews #IMCAS2026 #ChungwooMedical #APOLEXTite ...

 At IMCAS World 2026 in Paris, we met with plastic surgeon Dr. Carmelo Crisafulli at the CGBIO booth. As a global KOL for the CaHA biostimulator Facetem, he described the product as "one of the safest biostimulators on the market," highlighting what he described as a collagen-stimulating mechanism with a favorable inflammatory profile and the technological advantages of its proprietary Lattice-pore structure. He also noted the product's versatility across multiple treatment areas—including the face, neck, hands, and knees—and its adjustable dilution ratios, which allow practitioners to tailor applications from volume restoration to biostimulation. After visiting the Korean manufacturing facility firsthand, he shared that he was impressed by the quality standards and depth of supporting research data. His remarks reflect the broader global shift away from filler overinjection toward biostimulation, while also offering a firsthand view of how K-Medical Aesthetics is gaining...

 Part 2 of Dr. Hyunseok Nam's APOLEX TITE hands-on demonstration from Own Clinic Songdo. Following Part 1, this video explores optimal combination strategies with Ultherapy, Thermage, and thread lifting. Dr. Nam explains the recommended sequence and rationale when combining procedures on the same day, and presents methods to overcome the limitations of HIFU and RF monotherapy in patients with significant fat volume. The video also covers strategies for extending thread lifting duration with fewer threads after volume reduction. Learn how the device selectively breaks down adipocytes while preserving lymphatic structures, unlike traditional liposuction, and discover potential new indications including nodule removal following CaHA procedures.  #MedicalAestheticNews #ChungwooMedical #ApolexTite #OwnClinicSongdo #DrHyunseokNam ★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=11152

 VIOL Medical's global expansion is accelerating, with exports to 70 countries and the recent acquisition of EU MDR certification positioning the company for a strategic push into the European market. Dr. Edmond Lau, who has operated a medical aesthetic clinic in Penang, Malaysia for over 12 years, shared his clinical experience as a KOL for Sylfirm X at the VIOL Medical booth during IMCAS World Congress 2026. A self-described heavy laser user, he noted that "unlike conventional RF microneedling devices, Sylfirm X improves the extracellular matrix (ECM) microenvironment to promote healthier skin from within," offering a new alternative for patients with recalcitrant melasma who have failed years of laser therapy. He also spoke to the shifting global perception of K-Medical Aesthetics: "Ten years ago, I was skeptical about Korean-made devices. Today, both the medical community and the public trust Korean medical aesthetic technology."  #MedicalAestheticNews #IMCA...

 The global medical aesthetics market is shifting its focus from volumization to the body's own collagen production. Amid this trend, GOURI — the world's first fully liquid PCL collagen stimulator — is drawing significant attention. Unlike conventional particulate-based products, GOURI diffuses naturally throughout the skin upon injection, stimulating collagen production. Since obtaining European CE certification, the product has been marketed in over 50 countries, with Korean MFDS approval secured in October 2025. At IMCAS World Congress 2026 in Paris, GOURI KOL Dr. Seungmin Oh (ON Clinic) shared insights on data-driven protocol development, the distinct mechanism of liquid PCL, and the current standing of K-Medical Aesthetics — highlighted by over 50 Korean faculty speakers taking center stage.  #MedicalAestheticNews #IMCAS2026 #DEXLEVO #GOURI #CollagenStimulator #ONClinic #DrSeungminOh ★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=11261

 In the field of aesthetic medicine, high device utilization is more than a mere number — it represents accumulated clinical expertise and evidence of patient trust. The Top Rankers series spotlights physicians who have built outstanding usage records in their own practices. This installment features Dr. Kyeongrok Choi of Cheongdam Hin Clinic, who recorded the highest number of VirtueRF treatments in Korea in 2025. After working with various RF microneedling devices over 12 years, Dr. Choi chose VirtueRF for its patented cooling system and 0.5 MHz frequency combination. "Treating comprehensively rather than zone-by-zone is VirtueRF's competitive advantage," he emphasizes. From his signature layer-stacking protocol to combination strategies with Sunny Quasar tip and InMode MiniFX, Dr. Choi shares clinical insights gained from three years as a top-three user — with zero adverse events.  #MedicalAestheticNews #ShenB #VirtueRF #RFMicroneedling #CheongdamHinClinic #DrKyeongrok...

 As exosomes emerge as a standalone category in the global medical aesthetics market, Korean bio-innovation companies with proven technology platforms are drawing growing attention. Primoris International, a global bio-innovation company with a broad ingredient portfolio spanning umbilical cord blood stem cell-derived exosomes, plant-derived exosomes, and plant PDRN, has expanded into more than 50 countries, with over 1.7 million clinical-use cases, according to the company. At IMCAS World Congress 2026 in Paris, Seohyun Park, Director of External Relations, unveiled the company's flagship products — P198 ExoHealer and ExoNature — alongside next-generation biostimulator coll:Re and the hybrid line Epiglow, while announcing plans to enter 25 additional markets this year. For a closer look at Primoris International's technology-driven global strategy and the latest trends shaping the exosome landscape, read the full interview via the link in our bio. #MedicalAestheticNews #IMCAS2...

 On February 28–March 1, VAIM held its flagship academic symposium JUPITER 2026 at the Grand Hyatt Incheon, bringing together over 300 Korean medical professionals. Now in its fourth year, JUPITER serves as a peer-driven forum for sharing the latest science, efficacy data, and clinical applications of JUVELOOK. This year's central theme was the expansion of indications into hair regeneration, hair quality improvement, and gray hair. Prof. Kyunghee Byun of Gachon University presented new mechanistic data suggesting a Piezo1 channel–mediated mechanism activating hair follicle stem cells, providing a scientific foundation for JUVELOOK's potential as a "hair regenerator." Dr. Jino Kim of NEWHAiR supported these preclinical findings with real-world clinical data. The symposium also covered advances in reconstitution, biodegradation safety, hands-on protocols for JUVELOOK i, and the clinical outlook for VAIM's newest product, Juvèacell — highlighting VAIM's efforts ...

 Our IMCAS World 2026 special series takes us to Solta Medical's on-the-ground presence in Paris. At this year's congress, Solta Medical set up a dedicated showroom and Training Lab at a hotel directly across from the venue, showcasing four key product lines: Thermage FLX, Fraxel Dual, Clear + Brilliant, and Vaser. The Training Lab offered hands-on sessions covering the latest treatment protocols, while a VIP reception in the evening was attended by global KOLs. In Europe, unlike in Korea, Solta Medical actively promotes its laser portfolio in addition to Thermage FLX. Solta Medical Korea is also gearing up to bring new laser offerings to the domestic market, including a next-generation Fraxel and C+B Touch. Read the full article via the link in our bio. #MedicalAestheticNews #IMCAS2026 #IMCAS #KMedicalAesthetics #SoltaMedical #ThermageFLX ★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=11204

 Picosecond laser technology is evolving beyond pigmentation treatment and toning into facial contouring and skin tightening. Conventional HIFU carries a significant pain burden due to deep energy penetration, while RF microneedling remains limited to superficial treatment. PicoSculpting presents a novel non-thermal approach, leveraging LIOB (Laser-Induced Optical Breakdown) to precisely target the dermal collagen matrix — the sweet spot between these two modalities. LASEROPTEK's SCULPIO is a next-generation device engineered specifically for PicoSculpting. In this exclusive interview, Dr. Philip Werschler — U.S. board-certified dermatologist, Editor-in-Chief of JCAD, and pioneer of the PicoSculpting concept — discusses the scientific rationale and protocol development behind PicoSculpting, its safety profile in Asian skin types, combination strategies with toxins and fillers, and its clinical relevance in the post-Wegovy era.  #MedicalAestheticNews #LASEROPTEK #SCULPIO #PicoS...

 At IMCAS World 2026 in Paris, we spoke with Junghee Kim, Head of the Aesthetics Division at DNC Aesthetics, about the global strategy and market outlook for the CaHA filler Facetem. DNC Aesthetics markets the product domestically in Korea under the brand DCLASSY CaHA, while its parent company CGBIO manages international operations under the Facetem brand. Powered by its proprietary Lattice-pore technology, Facetem is now available in 32 countries, with expansion to 50 markets targeted this year. The company's HA filler line, Aileene, is also set for launch in over 30 countries, accelerating its global portfolio expansion. Hear firsthand perspectives on CaHA biostimulator market growth and the evolving global standing of K-Medical Aesthetics.  #MedicalAestheticNews #IMCAS2026 #KMedicalAesthetics #DNCAesthetics #CGBIO #Facetem #DCLASSYCaHA ★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=11231

 Biostimulators — injectable treatments that reactivate the skin's own collagen production — are establishing themselves as a new pillar of anti-aging medicine. While conventional fillers and skin boosters work by directly adding volume, biostimulators take a more fundamental approach: restoring firmness and volume by awakening the skin's intrinsic regenerative capacity. Dexlevo's GOURI, a next-generation biostimulator featuring the world's first fully liquefied form of polycaprolactone (PCL), has accumulated over four years of international use with close to one million syringes sold, building a robust evidence base for its safety and efficacy. Dr. Jimyung Seo of Galleria Dermatology (Gaepo Dogok branch) reports that patients can experience natural volume restoration and a noticeable tightening effect from just a single session, with the liquid formulation significantly reducing the risk of nodules or lumps. We sat down with Dr. Seo to hear her firsthand clinical insig...

 Chungwoo Medical, an RF technology-focused medical device manufacturer marking its 25th anniversary, showcased its microneedle RF system 'ELLISYS SENSE' and internal RF tightening device 'APOLEX Tite' at IMCAS World Congress 2026, signaling a renewed push into global markets. The company is rolling out a specialized eyelid tightening indication leveraging the ELLISYS SENSE's vacuum-assisted RF microneedling technology under the brand concept 'SENSE KISS,' with plans to scale across Europe, the Americas, and Latin America on the strength of its CE MDR certification. Speaking at the event in Paris, Vice President Suhee Nam noted, "The aesthetic device market has plateaued for five to six years, but there is still room to lead — if you can develop indications that competitors simply cannot replicate."  #MedicalAestheticNews #IMCAS2026 #ChungwooMedical #ELLISYSSENSE #SENSEKISS #APOLEXTite ★ Article Link: https://www.aestheticnews.co.kr/news/articleVie...

 The 'SHENB Paris Summit 2026,' held during IMCAS World Congress 2026 in Paris, showcased clinical experiences with microneedling RF device 'VirtueRF' and dual plasma device 'PLADUO,' drawing considerable interest from the global medical community. Four KOLs practicing in France, Russia, the UK, and Dubai addressed over 170 physicians and partners at the summit. Presentations highlighted VirtueRF's Advanced Cooling System (ACS), the clinical application of three frequencies (0.5/1/2 MHz), and six cases demonstrating post-procedural complication management. The 'Korean Glass Skin' protocol—utilizing PLADUO for inflammation control followed by VirtueRF—and the 'FIRE Signature' protocol were unveiled, underscoring the therapeutic synergy between the two devices.  #MedicalAestheticNews #IMCAS2026 #SHENB #VirtueRF #PLADUO ★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=11251

 Regen Biotech, backed by its new parent company Imeik Technology, has officially announced the global relaunch of AestheFill at IMCAS World Congress 2026 in Paris. Global Marketing Director Patrick Li revealed that the company has undergone a comprehensive restructuring and partner realignment following the acquisition, with plans to relaunch in European and Latin American markets this year. At IMCAS, Regen Biotech also unveiled its newly established global trainer panel — including Dr. Konstantin Frank and Dr. Kyuho Yi — alongside a large-scale investment plan in marketing, branding, and scientific education. AestheFill has established itself as the highest-priced premium collagen stimulator in China within just two years of its launch, while in Korea, the company is strengthening its partnership with Humedix and preparing to introduce a new 50mg skin booster formulation.  #MedicalAestheticNews #IMCAS2026 #RegenBiotech #AestheFill #Humedix #KMedicalAesthetics ★ Article Link:...

 Candela's Nordlys multi-application platform—combining IPL, non-ablative fractional, and Nd:YAG laser technologies in a single device—covers a broad range of indications including rosacea, port-wine stains, acne, and scarring, and is trusted by practitioners across every continent. At the Candela booth during IMCAS World Congress 2026, UK- and Denmark-based laser dermatologist Prof. Firas Al-Niaimi described Nordlys as a device he uses almost daily in clinic, sharing his approach to Expert Mode customization and multi-handpiece combination protocols for optimal outcomes. "Korean doctors are very innovative and skilled at combining different treatment modalities," he noted, adding that "the ability to share and exchange experiences across diverse skin types is the true value of global collaboration."  #MedicalAestheticNews #IMCAS2026 #Candela #Nordlys #ProfFirasAlNiaimi ★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=11250

 On February 21–22, Humedix held its medical aesthetic symposium 'HART Symposium II: The Origin' at The Westin Josun Busan, bringing together more than 150 physicians from Korea and abroad. With Dooyeol Chang (Change Clinic) serving as Day 1 moderator, Youngjin Park (Obliv Clinic) presented new clinical approaches to auricular filler procedures using Elravie Premier, Woong Choi (VS Line Clinic, Apgujeong) discussed safe AestheFill protocols and global market positioning strategies, and Bongkyun Ahn (MyD Dermatology Clinic) shared his insights into the ECM regeneration mechanisms and clinical experience with Elravie Re2O. The subsequent panel discussion featured additional panelists Sungjae Yoon (Leaders Dermatology, Apgujeong), Jung Min (Redi Dermatology), Jaewoo Song (Barog Clinic, Yuseong), and Hyunhee Lee (Lewell Clinic), who joined the moderator and lecturers for an in-depth exchange on immune response management, mixing strategies, and energy-based device combination proto...